Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029315
Filing Date
2019-08-06
Accepted
2019-08-06 16:02:01
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20190630.htm   iXBRL 10-Q 2644131
2 EX-10.1 aldr-ex101_128.htm EX-10.1 206655
3 EX-10.2 aldr-ex102_131.htm EX-10.2 77163
4 EX-10.3 aldr-ex103_130.htm EX-10.3 58858
5 EX-10.4 aldr-ex104_129.htm EX-10.4 58459
6 EX-31.1 aldr-ex311_7.htm EX-31.1 15471
7 EX-31.2 aldr-ex312_8.htm EX-31.2 15490
8 EX-32.1 aldr-ex321_6.htm EX-32.1 8568
  Complete submission text file 0001564590-19-029315.txt   9098521

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA aldr-20190630.xsd EX-101.SCH 56145
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20190630_cal.xml EX-101.CAL 64538
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20190630_def.xml EX-101.DEF 167916
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20190630_lab.xml EX-101.LAB 409112
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20190630_pre.xml EX-101.PRE 309264
14 EXTRACTED XBRL INSTANCE DOCUMENT aldr-10q_20190630_htm.xml XML 1603121
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 191001944
SIC: 2834 Pharmaceutical Preparations